Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Millis
J M
JM
Department of Surgery, University of Chicaog, Illinois 60637, USA.
Bruce
D S
DS
Newell
K A
KA
Piper
J B
JB
Woodle
E S
ES
Seaman
D S
DS
Baker
A L
AL
Hart
J
J
Dasgupta
K
K
Thistlethwaite
J R
JR
D000328:Adult; D001706:Biopsy; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000627:therapeutic use*; D013256:Steroids / Q000627:therapeutic use*; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D016559:Tacrolimus